Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index, and 1 are not checked yet.

China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations

Open access
Wang, Yong-Jun, Li, Zi-Xiao, Gu, Hong-Qiu, Zhai, Yi, Jiang, Yong, Zhao, Xing-Quan, Wang, Yi-Long, Yang, Xin, Wang, Chun-Juan, Meng, Xia, Li, Hao, Liu, Li-Ping, Jing, Jing, Wu, Jing, Xu, An-Ding, Dong, Qiang, Wang, David, Zhao, Ji-Zong · 2020 · Stroke and Vascular Neurology

Abstract

China faces the greatest challenge from stroke in the world. The death rate for cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million deaths in 2018. It ranked third among the leading causes of death behind malignant tumours and heart disease. The age-standardised prevalence and incidence of stroke in 2013 were 1114.8 per 100 000 population and 246.8 per 100 000 person-years, respectively. According to the Global Burden of Disease Study 2017, the years of life lost (YLLs) per 100 000 population for stroke increased by 14.6%; YLLs due to stroke rose from third highest among all causes in 1990 to the highest in 2017. The absolute numbers and rates per 100 000 population for all-age disability-adjusted life years (DALYs) for stroke increased substantially between 1990 and 2017, and stroke was the leading cause of all-age DALYs in 2017. The main contributors to cerebrovascular diseases include behavioural risk factors (smoking and alcohol use) and pre-existing conditions (hypertension, diabetes mellitus, dyslipidaemia and atrial fibrillation (AF)). The most prevalent risk factors among stroke survivors were hypertension (63.0%-84.2%) and smoking (31.7%-47.6%). The least prevalent was AF (2.7%-7.4%). The prevalences for major risk factors for stroke are high and most have increased over time. Based on the latest national epidemiological data, 26.6% of adults aged ≥15 years (307.6 million adults) smoked tobacco products. For those aged ≥18 years, age-adjusted prevalence of hypertension was 25.2%; adjusted prevalence of hypercholesterolaemia was 5.8%; and the standardised prevalence of diabetes was 10.9%. For those aged ≥40 years, the standardised prevalence of AF was 2.31%. Data from the Hospital Quality Monitoring System showed that 3 010 204 inpatients with stroke were admitted to 1853 tertiary care hospitals during 2018. Of those, 2 466 785 (81.9%) were ischaemic strokes (ISs); 447 609 (14.9%) were intracerebral haemorrhages (ICHs); and 95 810 (3.2%) were subarachnoid haemorrhages (SAHs). The average age of patients admitted was 66 years old, and nearly 60% were male. A total of 1555 (0.1%), 2774 (0.6%) and 1347 (1.4%) paediatric strokes (age <18 years) were identified among IS, ICH and SAH, respectively. Over one-third (1 063 892 (35.3%)) of the patients were covered by urban resident basic medical insurance, followed by urban employee basic medical insurance (699 513 (23.2%)) and new rural cooperative medical schema (489 361 (16.3%)). The leading risk factor was hypertension (67.4% for IS, 77.2% for ICH and 49.1% for SAH), and the leading comorbidity was pneumonia or pulmonary infection (10.1% for IS, 31.4% for ICH and 25.2% for SAH). In-hospital death/discharge against medical advice rate was 8.3% for stroke inpatients, ranging from 5.8% for IS to 19.5% for ICH. The median and IQR of length of stay was 10.0 (7.0–14.0) days, ranging from 10.0 (7.0–13.0) in IS to 14.0 (8.0–22.0) in SAH. Data from the Chinese Stroke Center Alliance demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS, ICH and SAH were 0.77±0.21, 0.72±0.28 and 0.59±0.32, respectively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/svn-2020-000457

Cites

21 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Crude mortality rate of cerebrovascular disease in Chinese residents by sex and region, National Mortality Surveillance System 2018.
Figure 1 Crude mortality rate of cerebrovascular disease in Chinese residents by sex and region, National Mortality Surveillance System 2018.CC BY-NC · PubMed Central
Figure 2 Crude mortality rate of cerebrovascular disease in Chinese urban residents by age and sex, National Mortality Surveillance System 2018.
Figure 2 Crude mortality rate of cerebrovascular disease in Chinese urban residents by age and sex, National Mortality Surveillance System 2018.CC BY-NC · PubMed Central
Figure 3 Crude mortality rate of cerebrovascular disease in Chinese rural residents by age and sex, National Mortality Surveillance System 2018.
Figure 3 Crude mortality rate of cerebrovascular disease in Chinese rural residents by age and sex, National Mortality Surveillance System 2018.CC BY-NC · PubMed Central
Figure 4 Crude mortality rate of cerebrovascular disease in Chinese residents, National Mortality Surveillance System 2005–2018.
Figure 4 Crude mortality rate of cerebrovascular disease in Chinese residents, National Mortality Surveillance System 2005–2018.CC BY-NC · PubMed Central
Figure 5 Age-specific prevalence of stroke per 100 000 of Chinese adults by sex, National Epidemiological Survey of Stroke in China 2013.
Figure 5 Age-specific prevalence of stroke per 100 000 of Chinese adults by sex, National Epidemiological Survey of Stroke in China 2013.CC BY-NC · PubMed Central
Figure 6 Incidence rates of stroke per 100 000 person-years of Chinese adults (≥20 years) by sex, National Epidemiological Survey of Stroke in China 2013.
Figure 6 Incidence rates of stroke per 100 000 person-years of Chinese adults (≥20 years) by sex, National Epidemiological Survey of Stroke in China 2013.CC BY-NC · PubMed Central
Figure 7 Current tobacco smoking rate for adults aged 15 years and older by age and sex, China Global Adult Tobacco Survey 2018.
Figure 7 Current tobacco smoking rate for adults aged 15 years and older by age and sex, China Global Adult Tobacco Survey 2018.CC BY-NC · PubMed Central
Figure 8 Comparison of Chinese adults’ food consumption, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 8 Comparison of Chinese adults’ food consumption, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 9 Proportion of fat-based energy for Chinese adults by region, Chinese Nutrition and Health Surveillance 1992, 2002 and 2010–2012.
Figure 9 Proportion of fat-based energy for Chinese adults by region, Chinese Nutrition and Health Surveillance 1992, 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 10 Salt intake for Chinese adults by region, Chinese Nutrition and Health Surveillance 1992, 2002 and 2010–2012.
Figure 10 Salt intake for Chinese adults by region, Chinese Nutrition and Health Surveillance 1992, 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 11 Prevalence of overweight among Chinese adults by regions and age groups, Chinese Nutrition and Health Surveillance 2002 and 2010–2012 (Chinese standard for body mass index).
Figure 11 Prevalence of overweight among Chinese adults by regions and age groups, Chinese Nutrition and Health Surveillance 2002 and 2010–2012 (Chinese standard for body mass index).CC BY-NC · PubMed Central
Figure 12 Prevalence of obesity among Chinese adults by regions and age groups, Chinese Nutrition and Health Surveillance 2002 and 2010–2012 (Chinese standard for body mass index).
Figure 12 Prevalence of obesity among Chinese adults by regions and age groups, Chinese Nutrition and Health Surveillance 2002 and 2010–2012 (Chinese standard for body mass index).CC BY-NC · PubMed Central
Figure 13 Prevalence of hypertension aged 35–75 years, China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project 2014–2017.
Figure 13 Prevalence of hypertension aged 35–75 years, China Patient-Centered Evaluative Assessment of Cardiac Events (PEACE) Million Persons Project 2014–2017.CC BY-NC · PubMed Central
Figure 14 Hypertension awareness rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 14 Hypertension awareness rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 15 Hypertension treatment rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 15 Hypertension treatment rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 16 Hypertension control rates for Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 16 Hypertension control rates for Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 17 Hypertension treatment and control rates for Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 17 Hypertension treatment and control rates for Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 18 Prevalence of dyslipidaemia in Chinese adults aged 18 years and above, Chinese Nutrition and Health Surveillance 2002, 2010–2012 and 2015.
Figure 18 Prevalence of dyslipidaemia in Chinese adults aged 18 years and above, Chinese Nutrition and Health Surveillance 2002, 2010–2012 and 2015.CC BY-NC · PubMed Central
Figure 19 Percentage of adults who reported having had a cholesterol check by regions and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 19 Percentage of adults who reported having had a cholesterol check by regions and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 20 Dyslipidaemia awareness rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 20 Dyslipidaemia awareness rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 21 Dyslipidaemia treatment rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.
Figure 21 Dyslipidaemia treatment rate of Chinese adults aged 18 years and above by region and sex, Chinese Nutrition and Health Surveillance 2002 and 2010–2012.CC BY-NC · PubMed Central
Figure 22 Prevalence of atrial fibrillation among adults aged ≥40 years by region and sex, China National Stroke Screening and Prevention Project 2014–2015.
Figure 22 Prevalence of atrial fibrillation among adults aged ≥40 years by region and sex, China National Stroke Screening and Prevention Project 2014–2015.CC BY-NC · PubMed Central
Figure 23 Distribution of hospitals and participants from the Hospital Quality Monitoring System in 2018.
Figure 23 Distribution of hospitals and participants from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 24 Proportion of stroke type for in-hospital patients with stroke from the Hospital Quality Monitoring System in 2018 stratified by province.
Figure 24 Proportion of stroke type for in-hospital patients with stroke from the Hospital Quality Monitoring System in 2018 stratified by province.CC BY-NC · PubMed Central
Figure 25 Risk factors or comorbidities for patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018.
Figure 25 Risk factors or comorbidities for patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 26 Risk factors or comorbidities for patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018.
Figure 26 Risk factors or comorbidities for patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 27 Risk factors or comorbidities for patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.
Figure 27 Risk factors or comorbidities for patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 28 Distribution of hospitals and participants from Chinese Stroke Center Alliance in 2018.
Figure 28 Distribution of hospitals and participants from Chinese Stroke Center Alliance in 2018.CC BY-NC · PubMed Central
Figure 29 Procedures for patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018.
Figure 29 Procedures for patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 30 Procedures for patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018.
Figure 30 Procedures for patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 31 Intervention for patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.
Figure 31 Intervention for patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 32 Proceduresfor patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.
Figure 32 Proceduresfor patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018.CC BY-NC · PubMed Central
Figure 33 In-hospital outcomes of patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge against medical advice.
Figure 33 In-hospital outcomes of patients with ischaemic stroke from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge against medical advice.CC BY-NC · PubMed Central
Figure 34 In-hospital outcomes of patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge against medical advice.
Figure 34 In-hospital outcomes of patients with intracerebral haemorrhage from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge against medical advice.CC BY-NC · PubMed Central
Figure 35 In-hospital outcomes of patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge without medical advice.
Figure 35 In-hospital outcomes of patients with subarachnoid haemorrhage from the Hospital Quality Monitoring System in 2018 by province, autonomous region, or municipality. DAMA, discharge without medical advice.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 2

  1. Li X , Zhang X . Annual data set on national mortality surveillance 2018. Beijing: China Science and Technology Press, 2019.
  2. Yang, 2005, Scheme of Chinese nutrition and health surveillance, Zhonghua Yu Fang Yi Xue Za Zhi, 7, 471

Cited by

See all 511

Metadata

Authors
Wang, Y.-J., Li, Z.-X., Gu, H.-Q., Zhai, Y., Jiang, Y., Zhao, X.-Q., Wang, Y.-L., Yang, X., Wang, C.-J., Meng, X., Li, H., Liu, L.-P., Jing, J., Wu, J., Xu, A.-D., Dong, Q., Wang, D., & Zhao, J.-Z.
Affiliations
  • Capital Medical University (CN)
  • Chinese Center For Disease Control and Prevention (CN)
  • Fudan University (CN)
  • Barrow Neurological Institute (US)
Venue
Stroke and Vascular Neurology
Publisher
BMJ
Published
2020-08-21
Volume
5
Issue
3
Pages
211-239
ISSN
  • 2059-8688 (ISSN-L)
  • 2059-8696
OpenAlex
W3080103475
Cited by
511
References
22
Citations by year
2026: 38 · 2025: 59 · 2024: 86 · 2023: 98 · 2022: 160 · 2021: 66 · 2020: 3
FWCI
58.63
Type
journal article
Language
en
Open access
Locations
  • Stroke and Vascular Neurology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Youth Programme (QML20180501)
  • Ministry of Science and Technology of the People’s Republic of China, National Key R&D Programme of China (2015BAI12B00, 2016YFC0901002, 2017YFC1307905, 2017YFC1310901)
  • National Natural Science Foundation of China (81801152)
  • Beijing Talents Project (2018000021223ZK03, 2018A13)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords
stroke epidemiology, cerebrovascular disease mortality, stroke incidence, stroke prevalence, years of life lost, disability-adjusted life years, stroke risk factors, hypertension, smoking, atrial fibrillation, diabetes mellitus, dyslipidemia, hypercholesterolemia, China, global burden of disease, hospital quality monitoring, stroke rehabilitation
MeSH terms
Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Cerebrovascular Disorders, Child, Child, Preschool, China, Female, Humans, Infant, Infant, Newborn, Life Style, Male, Middle Aged, Risk Factors, Sex Factors, Time Factors, Comorbidity, Incidence, Prevalence, Treatment Outcome, Age Distribution, Sex Distribution, Risk Assessment, Health Status Disparities, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. https://app.cochat.ai/papers/10.1136/svn-2020-000457
The paper
Wang, Y.-J., Li, Z.-X., Gu, H.-Q., Zhai, Y., Jiang, Y., Zhao, X.-Q., Wang, Y.-L., Yang, X., Wang, C.-J., Meng, X., Li, H., Liu, L.-P., Jing, J., Wu, J., Xu, A.-D., Dong, Q., Wang, D., & Zhao, J.-Z. (2020). China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2020-000457

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.